Skip to main content
Premium Trial:

Request an Annual Quote

Martine Piccart, Christos Sotiriou, Anne-Lise Børresen-Dale, Alan Hollingsworth, David Barker, and Mostafa Ronaghi

Premium
DiaGenic this week said that four international experts on breast cancer have joined its scientific advisory board.
 
The Norwegian diagnostics company named Martine Piccart and Christos Sotiriou,both professors of oncology at the Université Libre de Bruxelles in Brussels, Anne-Lise Børresen-Dale, head of the department of genetics at the Norwegian Radium Hospital in Oslo, Norway, and Alan Hollingsworth, the medical director of Mercy Women’s Center of Oklahoma City, to its SAB.
 

 
Microchip Biotechnologies, an early-stage company developing nanofluidic sample preparation and analysis tools, has named David Barker and Mostafa Ronaghi to its board of directors.
 

Barker is vice president and chief scientific officer of Illumina. Ronaghi is the co-founder of several biotech companies, including Pyrosequencing, ParAllele Biosciences, and NextBio. He is currently a principal investigator at the Stanford University Genome Center.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.